PARSIPPANY, N.J., Oct. 30, 2018 (GLOBE NEWSWIRE) — Aetna has announced that they will reimburse select ambulatory surgical centers (ASCs) for the use of EXPAREL® (bupivacaine liposome injectable suspension) as part of a pilot program in Florida and New Jersey. The purpose of the program is to incentivize the use of non-opioid therapies for postsurgical pain […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone